Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?-Reference-Cited by-同舟云学术

Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

Published:1992-02 Issue:2-3 Volume:28 Page:644-648
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Barnes D.M.,Smith P.J.,Millis R.R.,Bartkova J.,Camplejohn R.S.,Gullick W.J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Studies of the HER-2/neu proto-oncogene in human breast cancer;Slamon;Cancer Cells: 7 Molecular Diagnostics of Human Cancer,1989

3. c-erbB-2 oncoprotein expression in primary advanced breast cancer;Lovekin;Br J Cancer,1991

4. The long term prognostic significance of c-erbB-2 in primary breast cancer;Winstanley;Br J Cancer,1991

5. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes;Gullick;Br J Cancer,1991

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De-escalation of Surgical Intervention and Contemporary Management Recommendations for Lobular Neoplasia, Atypical Ductal Hyperplasia, and Ductal Carcinoma In Situ;Current Breast Cancer Reports;2023-05-04

2. Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial;Clinical Cancer Research;2021-08-11

3. In Situ Carcinomas of the Breast;The Breast;2018

4. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression;Virchows Archiv;2017-05-31

5. Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status;The Journal of Molecular Diagnostics;2017-03